{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:03:06Z","timestamp":1781330586653,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4144,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1600-6143.2011.03608.x","type":"journal-article","created":{"date-parts":[[2011,7,12]],"date-time":"2011-07-12T16:39:24Z","timestamp":1310488764000},"page":"1686-1695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Fibrosing Cholestatic Hepatitis in HIV\/HCV Co-Infected Transplant Patients\u2014Usefulness of Early Markers After Liver Transplantation"],"prefix":"10.1016","volume":"11","author":[{"given":"T.M.","family":"Antonini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sebagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Roque-Afonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Teicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sobesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Coilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vaghefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Vittecoq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Castaing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Duclos-Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2011.03608.x_bib1","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib2","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"Plos Med"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2007.09.010","article-title":"Mortality related to chronic hepatitis B and chronic hepatitis C in France: Evidence for the role of HIV coinfection and alcohol consumption","volume":"48","author":"Marcellin","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib4","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1053\/gast.2002.37061","article-title":"Influence of HIV infection on the response to Interferon therapy and the long-term outcome of chronic hepatitis B","volume":"123","author":"Di Martino","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib5","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jhep.2005.11.008","article-title":"Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection","volume":"44","author":"Vallet-Pichard","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib6","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2007.06.010","article-title":"Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.-Canadian multicenter study","volume":"47","author":"Br\u00e4u","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jhep.2008.02.009","article-title":"Are HIV-infected patients candidates for liver transplantation","volume":"48","author":"Samuel","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","article-title":"Liver transplantation in HIV-HCV and HIV-HBV coinfected patients: A large experience in a single centre","volume":"47","author":"Duclos-Vall\u00e9e","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/QAD.0b013e32832c2a37","article-title":"Long-term follow-up of liver transplanted HIV\/hepatitis B virus coinfected patients: Perfect control of hepatitis B virus replication and absence of mitochondrial toxicity","volume":"23","author":"Tateo","year":"2009","journal-title":"AIDS"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib10","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1600-6143.2006.01546.x","article-title":"Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C","volume":"6","author":"De Vera","year":"2006","journal-title":"Am J Transplant."},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840130122","article-title":"Hepatic histological findings after liver transplantation for chronic hepatitis B virus infection including a unique pattern of fibrosing cholestatic hepatitis","volume":"13","author":"Davies","year":"1991","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/jmv.20692","article-title":"Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users","volume":"78","author":"Morice","year":"2006","journal-title":"J Med Virol"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib13","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1128\/JCM.43.5.2363-2369.2005","article-title":"Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients","volume":"43","author":"Le Gal","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib14","first-page":"157","article-title":"Molecular typing for the MHC with PCR-SSP","volume":"1","author":"Welsh","year":"1999","journal-title":"Rev Immunogenet"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: An international consensus document","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.pas.0000152139.66524.ab","article-title":"The histologic pattern of \u201cbiliary tract pathology\u201d is accurate for the diagnosis of biliary complications","volume":"29","author":"Sebagh","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/lt.21011","article-title":"Early histologic changes in fibrosing cholestatic hepatitis C","volume":"13","author":"Dixon","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib19","doi-asserted-by":"crossref","unstructured":"Sebagh M, Yilmaz F, Karam V et al. The histological pattern of \u201cbiliary tract pathology\u201d is accurate for the diagnosis of biliary complications. Am J Surg Pathol 29: 318\u2013323.","DOI":"10.1097\/01.pas.0000152139.66524.ab"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jhep.2009.06.031","article-title":"Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantaiton in HIV-HCV coinfected patients (ANRS-HC08 \u201cTHEVIC\u201d trial)","volume":"51","author":"Samri","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib21","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/lt.20432","article-title":"Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C","volume":"11","author":"Russo","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib22","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/lt.20506","article-title":"Early HCV-associated stellate cell activation in aggressive recurrent HCV: What can liver allografts teach about HCV pathogenesis?","volume":"11","author":"Demetris","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib23","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/jlts.2003.50062","article-title":"Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite","volume":"9","author":"Gopal","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2011.03608.x_bib24","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/lt.21635","article-title":"Hepatitis C virus therapy in liver transplant recipients: Response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis","volume":"14","author":"Roche","year":"2008","journal-title":"Liver Transpl"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2011.03608.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522280460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522280460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2011.03608.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:53:35Z","timestamp":1761627215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522280460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1600613522280460"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03608.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrosing Cholestatic Hepatitis in HIV\/HCV Co-Infected Transplant Patients\u2014Usefulness of Early Markers After Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03608.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}